Clinical Trials

Status
Title Sort descending Intervention Sponsor Status
A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation Potlako intervention, Enhanced care Brigham and Women's Hospital Recruiting
An Extended Follow-Up Study of the HPV Vaccine Delayed Booster Trial University of Arizona Active, not recruiting
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer Exemestane, Laboratory Biomarker Analysis, Pharmacokinetic Study, Questionnaire Administration National Cancer Institute (NCI) Active, not recruiting
HPV-Based Screen-and-Treat Demonstration Project in Lilongwe VIA and thermocoagulation UNC Lineberger Comprehensive Cancer Center Active, not recruiting
Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer Biopsy, Extended Release Metformin Hydrochloride, Megestrol Acetate, Questionnaire Administration National Cancer Institute (NCI) Recruiting
Metformin and Nightly Fasting in Women With Early Breast Cancer Biospecimen Collection, Extended Release Metformin Hydrochloride, Monitoring, Nutritional Assessment, Short-Term Fasting M.D. Anderson Cancer Center Recruiting
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery Endoxifen Hydrochloride, Placebo Administration, Questionnaire Administration National Cancer Institute (NCI) Active, not recruiting
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens Bazedoxifene and Conjugated Estrogens University of Kansas Medical Center Recruiting
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients Questionnaire Administration, Recombinant Human Papillomavirus Nonavalent Vaccine, Biospecimen Collection, HPV Self-Collection National Cancer Institute (NCI) Active, not recruiting
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine National Cancer Institute (NCI) Active, not recruiting